These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 20298993)

  • 61. As time goes by?: the fallacy of thrombolysis in STEMI networks.
    von Scheidt W; Thilo C
    Clin Res Cardiol; 2011 Oct; 100(10):867-77. PubMed ID: 21717207
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Explaining discrepant mortality results between primary percutaneous transluminal coronary angioplasty and thrombolysis for acute myocardial infarction.
    Anderson JL; Karagounis LA; Muhlestein JB
    Am J Cardiol; 1996 Oct; 78(8):934-9. PubMed ID: 8888669
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Why does primary angioplasty not work in registries? Quantifying the susceptibility of real-world comparative effectiveness data to allocation bias.
    Sen S; Davies JE; Malik IS; Foale RA; Mikhail GW; Hadjiloizou N; Hughes A; Mayet J; Francis DP
    Circ Cardiovasc Qual Outcomes; 2012 Nov; 5(6):759-66. PubMed ID: 23149427
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Variation on a theme: CMR as the "one-stop shop" for risk stratification after infarction?
    Wu KC
    JACC Cardiovasc Imaging; 2009 Jul; 2(7):843-5. PubMed ID: 19608134
    [No Abstract]   [Full Text] [Related]  

  • 65. Primary angioplasty and thrombolysis for acute myocardial infarction: an evidence summary.
    Lieu TA; Gurley RJ; Lundstrom RJ; Parmley WW
    J Am Coll Cardiol; 1996 Mar; 27(3):737-50. PubMed ID: 8606291
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Blood transfusion after myocardial infarction: friend, foe, or double-edged sword?
    Alfonso F
    JACC Cardiovasc Interv; 2009 Jul; 2(7):633-5. PubMed ID: 19628186
    [No Abstract]   [Full Text] [Related]  

  • 67. The exclusion of the elderly and women from clinical trials in acute myocardial infarction.
    Gurwitz JH; Col NF; Avorn J
    JAMA; 1992 Sep; 268(11):1417-22. PubMed ID: 1512909
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Primary Percutaneous Coronary Intervention in Elderly Patients With Acute Myocardial Infarction　- An Analysis From a Japanese Nationwide Claim-Based Database.
    Uemura S; Okamoto H; Nakai M; Nishimura K; Miyamoto Y; Yasuda S; Tanaka N; Kohsaka S; Kadota K; Saito Y; Tsutsui H; Komuro I; Ikari Y; Ogawa H; Nakamura M
    Circ J; 2019 May; 83(6):1229-1238. PubMed ID: 31019165
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Is door-to-balloon time the best metric to assess successful treatment of STEMI?
    Conti CR
    Clin Cardiol; 2011 Jul; 34(7):408-9. PubMed ID: 21660992
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Regression analysis of percutaneous coronary intervention treatment-related time delay.
    MacDonald RD; Welsford M; Arntz HR
    Am J Cardiol; 2005 Jul; 96(2):322. PubMed ID: 16018865
    [No Abstract]   [Full Text] [Related]  

  • 71. Percutaneous coronary intervention in elderly patients: is it beneficial?
    Shanmugasundaram M
    Tex Heart Inst J; 2011; 38(4):398-403. PubMed ID: 21841868
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The continuing importance of prior stroke in STEMI patients.
    Sloan MA
    Am Heart J; 2004 Dec; 148(6):931-6. PubMed ID: 15632874
    [No Abstract]   [Full Text] [Related]  

  • 73. Acute coronary syndromes: Transport for PCI versus fibrinolysis--long-term data scrutinized.
    Van de Werf F
    Nat Rev Cardiol; 2010 Aug; 7(8):419-20. PubMed ID: 20657607
    [No Abstract]   [Full Text] [Related]  

  • 74. [Why controlled studies may lead to misleading and unconfirmed therapeutic concepts--a critical view of evidence-based medicine].
    Flachskampf FA
    Z Kardiol; 2002 Mar; 91(3):197-202. PubMed ID: 12001535
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Acute coronary artery disease in the elderly: less ventured, less gained.
    Scheidt S; Wenger N; Weber M
    Am J Geriatr Cardiol; 2006; 15(1):5-6. PubMed ID: 16415639
    [No Abstract]   [Full Text] [Related]  

  • 76. Percutaneous intervention in the very elderly: weighing the risks and benefits.
    Peterson ED; Batchelor WB
    Am Heart J; 1999 Apr; 137(4 Pt 1):585-7. PubMed ID: 10097215
    [No Abstract]   [Full Text] [Related]  

  • 77. [Comparative analysis of indications and results of percutaneous coronary angioplasties according to age].
    Nellessen E; Martinez C; Legrand V
    Rev Med Liege; 1997 Apr; 52(4):230-6. PubMed ID: 9273613
    [No Abstract]   [Full Text] [Related]  

  • 78. Diagnostic expansion in clinical trials: myocardial infarction, stroke, cancer recurrence, and metastases may not be the hard endpoints you thought they were.
    Nishikawa G; Prasad V
    BMJ; 2018 Sep; 362():k3783. PubMed ID: 30232089
    [No Abstract]   [Full Text] [Related]  

  • 79. Management of Acute Coronary Syndromes in Older People: Comprehensive Review and Multidisciplinary Practice-Based Recommendations.
    Narendren A; Whitehead N; Burrell LM; Yudi MB; Yeoh J; Jones N; Weinberg L; Miles LF; Lim HS; Clark DJ; Al-Fiadh A; Farouque O; Koshy AN
    J Clin Med; 2024 Jul; 13(15):. PubMed ID: 39124683
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Unsolved Questions in the Revascularization of Older Myocardial Infarction Patients with Multivessel Disease.
    Pavasini R; Sanguettoli F; Zanarelli L; Deserio MA; Bianchi N; Fabbri G; Tebaldi M; Biscaglia S; Campo G
    Rev Cardiovasc Med; 2022 Oct; 23(10):344. PubMed ID: 39077134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.